secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytoDyn Inc. (CYDY)
CIK:        0001175680
Form:       8-K
Filed at:   2022-12-19T23:59:59+00:00
Accession:  0001558370-22-018797
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CytoDyn CMO Scott A. Kelly resigns effective immediately
--------------------------------------------------------

- Scott A. Kelly, M.D., resigns as Chief Medical Officer of CytoDyn on December 19, 2022.
- Resignation effective immediately; no reason provided in the filing.
- No replacement named; search for new CMO presumably underway.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175680/000155837022018797/0001558370-22-018797-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175680/000155837022018797/cydy-20221219x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-018797

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer